Abstract:Nicotinamide Adenine Dinucleotide (NAD) is an endogenous substance in redox reactions and regulates various functions in metabolism. NAD and its precursors are known for their anti-ageing and anti-obesity properties and are mainly active in the liver and muscle. Boosting NAD+ through supplementation with the precursors, such as nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR), enhances insulin sensitivity and circadian rhythm in the liver, and improves mitochondrial function in the muscle. Recent evidence has revealed that the adipose tissue could be another direct target of NAD supplementation by attenuating inflammation and fat accumulation. Moreover, murine studies with genetically modified models demonstrated that nicotinamide phosphoribosyltransferase (NAMPT), a NAD regulatory enzyme that synthesizes NMN, played a critical role in lipogenesis and lipolysis in an adipocyte-specific manner. The tissue-specific effects of NAD+ metabolic pathways indicate a potential of the NAD precursors to control metabolic stress particularly via focusing on adipose tissue. Therefore, this narrative review raises an importance of NAD metabolism in white adipose tissue (WAT) through a variety of studies using different mouse models.

What problem does this paper attempt to address?

This paper provides an overview of the role of NAD (Nicotinamide adenine dinucleotide) metabolism in white adipose tissue and lessons learned from mouse models. NAD is an endogenous substance that participates in redox reactions and regulates multiple metabolic functions. Its precursors, such as NMN and NR, are believed to have anti-aging and anti-obesity properties. Studies have found that supplementing NAD precursors can enhance insulin sensitivity and circadian rhythm in the liver, improve mitochondrial function in muscles, and recent evidence suggests that NAD metabolism may also directly affect adipose tissue, reducing inflammation and fat accumulation. The paper points out that NAD metabolism in adipose tissue plays a key role in regulating lipid synthesis and breakdown through the enzyme NAMPT. NAMPT specifically affects lipid metabolism in adipocytes, and the tissue-specificity of NAD+ metabolism pathways suggests that NAD precursors may control metabolic stress by targeting adipose tissue. However, the specific role of NAD metabolism in adipose tissue remains inconsistent in current research. The paper also discusses the biosynthetic pathways of NAD+, including de novo synthesis from tryptophan and salvage pathways through NAD+ recycling. Increasing NAD+ levels can improve metabolic function by enhancing SIRT1 activity in the liver and muscles, while in adipose tissue, deficiency of NAMPT may result in fat accumulation and inflammation. Finally, the paper mentions that although there is relatively less research on the impact of NAD+ precursors on white adipose tissue, existing evidence suggests that these precursors can reduce fat accumulation and inflammation. However, experiments using genetically modified mouse models have produced inconsistent results, possibly due to gender and age differences or the influence of intracellular NAD+ baseline levels. Therefore, more research is needed in the future to fully understand the role of NAD+ supplements and the unique function of NAMPT in adipocyte development and metabolism.

Function of NAD metabolism in white adipose tissue: lessons from mouse models